Roberto Berni Canani | Non-Communicable Diseases | Research Excellence Award

Research Excellence Award

Roberto Berni Canani
Università degli Studi di Napoli Federico II, Italy

                 Roberto Berni Canani
Affiliation Università degli Studi di Napoli Federico II
Country Italy
Scopus ID 57008139600
Documents 330
Citations 26,391
h-index 72
Subject Area Non-Communicable Diseases
Event Global Diseases Research Awards
ORCID 0000-0002-5169-9574

Roberto Berni Canani is a researcher affiliated with the Università degli Studi di Napoli Federico II, Italy, whose academic profile encompasses pediatric medicine, nutrition, gastroenterology, allergy, microbiome research, and food-related diseases. His research integrates clinical and translational perspectives, contributing to scientific understanding of gastrointestinal health, nutrition-related mechanisms, immune responses, and disease prevention within biomedical research. [1]

Abstract

Roberto Berni Canani is an Italian researcher affiliated with the Università degli Studi di Napoli Federico II whose academic activities encompass pediatric medicine, nutrition, gastroenterology, allergy, microbiome research, and food-related diseases. His research profile reflects multidisciplinary investigation connecting clinical medicine with nutritional, immunological, gastrointestinal, and translational research. The supplied Scopus information records 330 documents, 26,391 citations, and an h-index of 72. His scientific work addresses relationships between nutrition, intestinal biology, immune responses, allergic conditions, and disease mechanisms, contributing to evidence-based understanding of health and disease. These research areas provide a relevant academic foundation for consideration for the Research Excellence Award within the Global Diseases Research Awards. [2]

Keywords

Roberto Berni Canani, Research Excellence Award, pediatric medicine, gastroenterology, nutrition, allergy, microbiome, food-induced diseases, gastrointestinal health, immunology, translational research, non-communicable diseases, biomedical research, Università degli Studi di Napoli Federico II, Italy. [2]

Introduction

Research into nutrition, gastrointestinal health, allergy, and immune-mediated disease has become increasingly interdisciplinary, combining clinical investigation with biological and nutritional sciences. Roberto Berni Canani’s academic profile is positioned within these interconnected fields, with research addressing pediatric health and disease mechanisms. His institutional affiliation provides an academic setting for multidisciplinary scientific investigation and collaboration.[1]

Research Profile

Roberto Berni Canani is affiliated with the Università degli Studi di Napoli Federico II and has an academic research profile indexed through Scopus. The supplied record identifies 330 documents, 26,391 citations, and an h-index of 72. His research interests encompass nutrition, pediatric gastroenterology, allergy, microbiome science, and food-related disease research.[1]

Research Contributions

Berni Canani’s research contributions include investigation of relationships among nutrition, gastrointestinal function, immune responses, and allergic disease. These areas are relevant to understanding how dietary exposures and biological processes interact in childhood health. His work illustrates an interdisciplinary research approach combining clinical questions with nutritional, immunological, and translational perspectives.[2]

Publications

The researcher’s publication record covers scientific topics associated with pediatric allergy, nutrition, gastrointestinal disorders, and related biomedical disciplines. His scholarly output contributes to peer-reviewed scientific communication and supports continuing investigation of mechanisms underlying disease and health. Publication activity also provides a basis for evaluating research development, collaboration, and dissemination across relevant academic communities.[1]

Research Impact

The supplied Scopus profile records 330 documents, 26,391 citations, and an h-index of 72, providing quantitative indicators of the visibility of the researcher’s indexed scholarly output. Such bibliometric measures offer useful context when assessing academic activity, although research impact is more comprehensively considered alongside publication quality, originality, collaboration, and substantive scientific contribution.[3]

Award Suitability

The documented academic profile is relevant to a Research Excellence Award because it demonstrates sustained scholarly activity across several interconnected biomedical disciplines. His research focus on nutrition, allergy, gastrointestinal health, microbiome-related science, and pediatric disease provides a multidisciplinary foundation for evaluation. The available publication and citation indicators further support consideration within an academic recognition framework.[4]

Conclusion

Roberto Berni Canani’s academic profile reflects sustained research activity in pediatric medicine, nutrition, gastroenterology, allergy, and related biomedical fields. His documented scholarly indicators and multidisciplinary research interests provide a substantial basis for academic evaluation. His work demonstrates the relevance of integrating clinical, nutritional, immunological, and translational perspectives in contemporary health research.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Roberto Berni Canani, Author ID 57008139600. Scopus.
    https://www.scopus.com/pages/authors/57008139600
  2. Global Diseases Research Awards. (n.d.). Research Excellence Award Recognition. Global Diseases Research Awards.
    https://globaldiseases.org/
  3. Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B., Morelli, L., Canani, R. B., Flint, H. J., Salminen, S., Calder, P. C., & Sanders, M. E. (2014). Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology, 11(8), 506–514.
    https://doi.org/10.1038/nrgastro.2014.66
  4. Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B., Morelli, L., Berni Canani, R., Flint, H. J., Salminen, S., Calder, P. C., & Sanders, M. E. (2014). The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology, 11, 506–514.
    https://doi.org/10.1038/nrgastro.2014.66
  5. Canani, R. B., Di Costanzo, M., Leone, L., Pedata, M., Meli, R., & Calignano, A. (2011). Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World Journal of Gastroenterology, 17(12), 1519–1528.
    https://doi.org/10.3748/wjg.v17.i12.1519

 

Olawunmi Oyedeji | Oncology | Innovative Research Award

Innovative Research Award

Olawunmi Oyedeji
The Christie NHS Foundation Trust

                          Olawunmi Oyedeji
Affiliation The Christie NHS Foundation Trust
Country United Kingdom
Scopus ID 58803277000
Documents 2
Citations 2
h-index 2
Subject Area Oncology
Event Global Diseases Research Awards
ORCID 0009-0008-0626-3422

Olawunmi Oyedeji is a researcher affiliated with The Christie NHS Foundation Trust, United Kingdom, whose academic activities contribute to the field of oncology research. The Innovative Research Award recognizes researchers demonstrating valuable contributions through scientific investigation, clinical advancement, and knowledge development within their respective disciplines. [1]

Abstract

The Innovative Research Award highlights academic excellence and meaningful contributions in oncology research. Olawunmi Oyedeji, affiliated with The Christie NHS Foundation Trust, United Kingdom, represents emerging research activities focused on advancing healthcare knowledge and improving scientific understanding. With documented publications, citations, and research engagement indexed through Scopus, the researcher demonstrates participation in scholarly communication. The award recognizes dedication toward innovative approaches, evidence-based practices, and contributions supporting progress in global disease research and clinical advancement. [1]

Keywords

Oncology Research, Clinical Research, Innovative Research Award, Cancer Research, Healthcare Innovation

Introduction

Oncology research plays an important role in understanding cancer biology, improving diagnosis, and developing effective therapeutic strategies. Researchers working within clinical and academic institutions contribute essential evidence that supports improvements in patient care and healthcare systems. [2]

Research Profile

Olawunmi Oyedeji is associated with The Christie NHS Foundation Trust, a leading healthcare institution in the United Kingdom. The research profile includes two indexed documents, two citations, and an h-index of two according to available Scopus information. [1]

Research Contributions

The researcher’s contributions are positioned within oncology and healthcare research. Scientific contributions in this area support better understanding of diseases, treatment approaches, clinical methodologies, and evidence-based medical practices. Such efforts strengthen collaborative research environments and promote advancement in cancer-related knowledge. [2]

Publications

The researcher has published scholarly documents indexed within Scopus databases. These publications contribute to academic discussions in oncology and related healthcare disciplines. Research outputs provide opportunities for knowledge exchange and future scientific collaboration among international researchers. [3]

Research Impact

Research impact is reflected through scholarly visibility, citation activity, and contribution to scientific literature. The available metrics indicate participation in academic research communication and demonstrate the importance of continued investigation within oncology and clinical sciences. [4]

Award Suitability

The Innovative Research Award recognizes researchers who demonstrate commitment toward scientific advancement and meaningful research activities. Based on the researcher’s oncology-focused profile, institutional affiliation, and academic contributions, Olawunmi Oyedeji represents a suitable candidate for recognition within the Global Diseases Research Awards framework. [4]

Conclusion

Olawunmi Oyedeji’s research profile demonstrates involvement in oncology-related scientific activities through institutional association, publications, and academic indexing. The Innovative Research Award acknowledges continued efforts toward research development and contributions supporting healthcare innovation and global scientific progress.

External Links

References

  1. Elsevier. (n.d.). Scopus author details: Olawunmi Oyedeji, Author ID 58803277000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58803277000
  2. Global Diseases Research Awards. (n.d.). Innovative Research Award Information.
    https://globaldiseases.org/
  3. Oisakede, E. O., Oyedeji, O. O., Olawuyi, O. F., Alabi, J. O., Daniel, R. I. A., & Olawade, D. B. (2026). Nanoparticle-mediated cardiotoxicity and nanomedicine interventions in cancer treatment. Nano TransMed, 5, Article 100113.
    https://doi.org/10.1016/j.ntm.2026.100113
  4. Oyedeji, O. O., & Oisakede, E. O. (2026). Radiation-induced rhinosinusitis after treatment of nasopharyngeal and selected sinonasal cancers: A narrative review. Sinusitis, 10(1), Article 100015.
    https://doi.org/10.3390/sinusitis10010015

Hsuan Liu | Cancer Genomics | Research Excellence Award

Prof. Dr . Hsuan Liu | Cancer Genomics | Research Excellence Award

Chang Gung University | Taiwan

Dr. Hsuan Liu is a distinguished researcher at Chang Gung University, recognized for impactful contributions across interdisciplinary scientific domains. With 58 publications and 1,736 citing documents, Dr. Liu’s work demonstrates strong scholarly influence and sustained research productivity. An h-index of 21 reflects both consistency and depth of academic impact. Collaborating with more than 300 co-authors, Dr. Liu contributes to advancing knowledge through extensive international and cross-disciplinary partnerships. Their research outputs not only strengthen scientific understanding but also support societal progress by informing innovative solutions, enhancing academic discourse, and contributing to global research excellence.

Citation Metrics (Scopus)

1,781
1,000
500
250
0

Citations

1,781

Documents

58

h-index

21

Citations

Documents

h-index


View Scopus ProfileView ORCID Profile

 

Top 5 Featured Publications